CURLF stock sentiment todayCuraleaf Holdings, Inc.
Sentiment verdict
Gossip first, financials second — HOT at 85% confidence.
Last updated · cached analysis, refreshes periodically
CURLF
Curaleaf Holdings, Inc.The 11.44% jump reflects massive momentum as Curaleaf positions itself as the primary beneficiary of US federal rescheduling and international expansion.
Pick a name and you can add your own 1-, 3- and 6-month price calls — no account needed. The needle above shows where the crowd sits. Calls lock 48 hours after you make them, so every scorecard stays honest.
You'll show up on boards and The Floor under this name. Add an email later to keep your history.
No account needed. You can add an email later to keep your calls.
Already have an account? Sign in
See exactly how analyst targets, gossip sentiment and momentum are weighted into this 6-month forecast.
Sign in to go Pro →Full model breakdown (analyst / gossip / momentum weights) is a Pro feature. Modelled for CURLF. Not financial advice.
Price · last 12 months
Gossip
The market is currently hyper-focused on the DEA's move to reschedule cannabis to Schedule III, which would eliminate the 280E tax burden. Curaleaf is widely viewed as the 'blue chip' of MSOs (Multi-State Operators) due to its massive footprint and recent uplisting to the Toronto Stock Exchange (TSX), increasing institutional accessibility.
- ·DEA Schedule III rescheduling momentum
- ·SAFER Banking Act legislative hopes
- ·Expansion into Germany's newly liberalized medical market
- ·Anticipation of Ohio and Florida adult-use market launches
Financial
While Curaleaf boasts the highest revenue in the US cannabis space, its bottom line remains pressured by high interest expenses and tax burdens. However, it maintains a industry-leading gross margin (approx. 45-50%) and has successfully pivoted toward free cash flow generation in recent quarters.
- ·Annual revenue exceeding $1.3 billion
- ·Positive Adjusted EBITDA with improving margins
- ·High debt load but manageable via recent refinancing
- ·Potential 280E tax savings could exceed $150M annually
Conviction
Whose money is actually in the stock — insider open-market trades and the patience of the institutional holder base.
Mixed conviction — no decisive signal from insiders or the holder base.
- ·No open-market insider trades in the last 120 days.
Pro shows every named insider trade in the window (buyer, title, size, price, and whether it was a pre-scheduled 10b5-1 sale) plus the full holder register split into patient capital and fast money.
Unlock with Pro →Source: SEC EDGAR Form 4. Option exercises, grants, gifts and tax withholding are excluded — only open-market purchases and sales count. Not financial advice.
Risks
- ·Federal legalization delays or legislative gridlock
- ·High cost of capital compared to non-cannabis CPG firms
- ·Price compression in mature markets like Colorado and Oregon
Peer temperature
How direct competitors stack up against CURLF right now.
- HOTGTBIFGreen Thumb Industries
HOTTER — Maintains superior profitability and consistent GAAP net income, which Curaleaf still lacks.
See full analysis → - NEUTRALTCNNFTrulieve Cannabis
COLDER — Highly concentrated in Florida; while they lead that market, they lack Curaleaf's geographic and international diversification.
See full analysis → - NEUTRALVRNOFVerano Holdings
COLDER — Trading at a lower valuation multiple but lacks the massive scale and brand recognition of Curaleaf's Select brand.
See full analysis →
- CURLF-6.1%
- GTBIF-1.5%
- TCNNF—
- VRNOF—
AI-generated analysis for informational purposes only. Not financial advice.